Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Deferoxamine mesilate

EU orphan designation number: EU/3/04/231
Active ingredient: Deferoxamine mesilate
Indication: Treatment of traumatic spinal cord injury
Sponsor: SCT Spinal Cord Therapeutics GmbH
Max-Planck-Strasse 15a, D-40699 Erkrath, Deutschland

   Public summary of scientific opinion    


European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
25/10/2004 Centralised Orphan - Designation EMEA/OD/014/04 (2004)4197 of 20/10/2004
16/05/2006 Other procedure
05/06/2009 Other procedure
28/02/2013 Centralised Orphan - Removal of orphan designation from Community Register